This is a preview of subscription content, access via your institution.

References
Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116(14):35–40. https://doi.org/10.1182/blood-2010-04-280347.
Bride KL, Vincent T, Smith-Whitley K, Lambert MP, Bleesing JJ, Seif AE, et al. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. Blood. 2016;127(1):17–28. https://doi.org/10.1182/blood-2015-07-657981.
Neven B, Magerus-Chatinet A, Florkin B, Gobert D, Lambotte O, de Somer L, et al. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood. 2011;118(18):4798–807. https://doi.org/10.1182/blood-2011-04-347641.
Aubrey-Bassler FK, Sowers N. 613 cases of splenic rupture without risk factors or previously diagnosed disease: a systematic review. BMC Emerg Med. 2012;12. https://doi.org/10.1186/1471-227X-12-11.
Kis B, Mills M, Smith J, Choi J, Sagatys E, Komrokji R, et al. Partial splenic artery embolization in 35 cancer patients: results of a single institution retrospective study. J Vasc Interv Radiol. 2019;31(4):584–91. https://doi.org/10.1016/j.jvir.2019.05.031.
Foley PT, Kavnoudias H, Cameron PU, Czarnecki C, Paul E, Lyon SM. Proximal versus distal splenic artery embolisation for blunt splenic trauma: what is the impact on splenic immune function? Cardiovasc Intervent Radiol. 2015;38(5):1143–51. https://doi.org/10.1007/s00270-015-1162-8.
Haas JP, Grunke M, Frank C, Kolowos W, Dirnecker D, Leipold G, et al. Increased spontaneous in vitro apoptosis in double negative T cells of humans with a fas/apo-1 mutation. Cell Death Differ. 1998;5(9):751–7. https://doi.org/10.1038/sj.cdd.4400426.
Peters AMJ, Kohfink B, Martin H, Griesinger F, Wörmann B, Gahr M, et al. Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin’s disease. Exp Hematol. 1999;27(5):868–74. https://doi.org/10.1016/S0301-472X(99)00033-8.
Acknowledgments
We thank Katsuki Hirai and Yuichiro Muto, the medical staff of the pediatric intensive care unit at the Japanese Red Cross Kumamoto Hospital for participating in the patient treatment. We would like to thank Editage (www.editage.com) for English language editing.
Author information
Authors and Affiliations
Contributions
Conceptualization: K.K., M.M.; writing: K.K., T.S., K.Y.; investigation: H.K.; supervision: T.A., H.K., K.N. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 585 kb)
Rights and permissions
About this article
Cite this article
Kohrogi, K., Migita, M., Anan, T. et al. Successful Artery Embolization in a Patient with Autoimmune Lymphoproliferative Syndrome Associated with Splenic Rupture. J Clin Immunol 40, 780–782 (2020). https://doi.org/10.1007/s10875-020-00809-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-020-00809-3